Literature DB >> 8298930

Pancreatic necrosis: assessment of outcome related to quality of life and cost of management.

D Fenton-Lee1, C W Imrie.   

Abstract

Ten patients with necrotizing pancreatitis admitted consecutively between August 1990 and August 1991 were studied. They comprised eight men and two women of median age 63 (range 29-73) years. One patient died. The median length of hospital stay was 74 (range 40-150) days. The median number of operations and endoscopic procedures performed per patient was 4 (range 2-7). Investigations performed included multiple bacteriological, radiological, haematological and biochemical tests. The mean cost of management was 18,441 pounds (range 9,296 pounds-33,796 pounds), of which hospitalization accounted for 65 per cent, operations and endoscopic procedures 20 per cent and investigations 16 per cent. Cost-utility analysis demonstrated a mean benefit per patient of 8.55 quality-adjusted life years gained at a cost of 2,157 pounds each. The management of pancreatic necrosis is expensive but justified by the excellent outcome in terms of quality of life.

Entities:  

Mesh:

Year:  1993        PMID: 8298930     DOI: 10.1002/bjs.1800801228

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  24 in total

1.  Determination of patient quality of life following severe acute pancreatitis.

Authors:  David Hochman; Brian Louie; Robert Bailey
Journal:  Can J Surg       Date:  2006-04       Impact factor: 2.089

Review 2.  [Late complications of open abdomen].

Authors:  F Eder; J Tautenhahn; H Lippert
Journal:  Chirurg       Date:  2006-07       Impact factor: 0.955

3.  A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England.

Authors:  S K Toh; S Phillips; C D Johnson
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

4.  Long-term health-related quality of life in survivors of severe acute pancreatitis.

Authors:  Kimmo I Halonen; Ville Pettilä; Ari K Leppäniemi; Esko A Kemppainen; Pauli A Puolakkainen; Reijo K Haapiainen
Journal:  Intensive Care Med       Date:  2003-04-09       Impact factor: 17.440

5.  Multidisciplinary Approach to Treating Severe Acute Pancreatitis in a Low-Volume Hospital.

Authors:  Alvaro Robin-Lersundi; Ana Abella Alvarez; Carlos San Miguel Mendez; Almudena Moreno Elalo-Olaso; Arturo Cruz Cidoncha; Asunción Aguilera Velardo; Federico Gordo Vidal; Miguel-Angel García-Ureña
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

6.  Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience.

Authors:  C R Carter; C J McKay; C W Imrie
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

7.  Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.

Authors:  Sakhawat H Rahman; Krishna V Menon; John H M Holmfield; Michael J McMahon; J Pierre Guillou
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 8.  Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.

Authors:  Eduardo Villatoro; Mubashir Mulla; Mike Larvin
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

Review 9.  Acute pancreatitis: the substantial human and financial costs.

Authors:  J P Neoptolemos; M Raraty; M Finch; R Sutton
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

10.  Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort study.

Authors:  Yun-Shing Peng; Cheng-Shyong Wu; Yung-Chang Chen; Jau-Min Lien; Ya-Chung Tian; Ji-Tseng Fang; Chun Yang; Yun-Yi Chu; Chien-Fu Hung; Chih-Wei Yang; Pang-Chi Chen; Ming-Hung Tsai
Journal:  Crit Care       Date:  2009-07-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.